It is possible that at least one of the potentially many types of neurotoxins produced by Borrelia burg. is ammonia. I postulate that the various and many neurological symptoms seen in LD are the result of small amounts of ammonia affecting localized areas of the brain, as opposed to the brain swelling due to liver problems, which affects the astrocytes of the entire brain.
The way I see it is that Bb release NH3, which is converted to glutamine, by way of the glutamine synthetase pathways, leading to localized swelling of astrocytes. Depending upon the severity of infection and tissue environmental issues, including pH, temperature, oxygen levels, emotional state… the amount of ammonia could cause variable and cyclical worsening of symptoms.
The Bb in joints and musculoskeletal tissues may be creating symptoms due to the conversion of NH3 to nitric oxide (NO), which is well documented as causing multiple pathological processes, including sepsis, hyperactive inflammatory processes, and joint pain. Direct resonance testing has revealed that the liver and heart are often testing positive to accumulations of NH3, which is not being converted into urea or nitric oxide.
Once the ammonia levels are cleared and the Bb microbes are reduced, supplemental L-arginine can be taken in the morning to “wake up” or energize the brain. (L-arginine should not be taken in the presence of ammonia. Research reveals that NH3 + arginine and manganese increases nitric oxide (NO) up to 53% in astrocytes, leading to increased brain swelling). Armed with this knowledge, health care professionals would be wise to instigate a protein poor diet for Lyme patients, during treatment to minimize aggravations from arginine.
The “Direct Resonance Testing,” molecular vibration phenomenon is not theory. Complex molecules may contain thousands or even millions of atoms. How they bind together creates an electromagnetic "signature," which is extremely precise and specific to the type of molecule. It is this molecular resonance that enables a doctor to perform a simple, quick test to determine the presence of ammonia in the brain or any other tissue. The same can be done as a quick screen for Bb, using a fixed Bb specimen.
Using "Direct Resonance Testing"
This is a simple test that can help screen Lyme patients for the presence of ammonia in various regions of the brain. I have found virtually every Lyme patient tests positive to having ammonia in specific locations of the brain. (Jernigan Nutraceuticals sells vials of Ammonia for $10.00) To perform a direct resonance test the doctor will need a vial of pure ammonia. A muscle strength challenge should be performed to identify a strong muscle, preferably using the deltoid muscle with the patient's thumb pointing towards the feet. The muscle should "lock" immediately when challenged, without being spongy. Once a good strong muscle has been identified, hold the vial of ammonia over various areas of the brain, testing to see if the previously strong muscle goes weak when the ammonia is held over any area. Due to the temporary neuromuscular interference caused by the harmonic resonance of ammonia in the vial with the ammonia present in the brain, the strong muscle will go weak. The best effective treatment can be identified by adding the corrective substance, be it the liquid botanical supplement, Blue Sage, the Neuro-Antitox II Formulas (Jernigan Nutraceuticals) or prescription Cholestyramine. To determine the best corrective substance, hold the vial of ammonia and a corrective substance over the same spot where the strong muscle went weak. If you have found the proper corrective substance the former weak muscle test now will go strong.
In summary, I know of no other testing method that provides such immediate confirmation of localized NH3 as the Direct Resonance Test. Localized ammonia is present in virtually every chronic LD patient, either from the spirochete or other indirect mechanism. We have found ammonia wherever Lyme spirochetes reside in the body, but primarily over the liver, heart, teeth, and cranium.
Hope this information helps you,
Sincerely, Dr. Sara J
Neurophotonic Therapy is trademarked, and its scientific foundations were originally researched, developed, and reported by Dr. David A. Jernigan, D.C. This is copywritten material and should be referenced accordingly.Localized Ammonia Production by Lyme Spirochetes
By David A. Jernigan, D.C.
*These comments have not been approved by the FDA. This product is not intended to treat, diagnose, or address disease. All of the products in the Jernigan Nutraceutical product line, work to enhance and support the restoration of structure and function of the body’s crystalline matrix. Always consult with your health care professional before beginning this or any other dietary supplement.